MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GUND, P.
Right arrow Articles by HOOGSTEEN, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GUND, P.
Right arrow Articles by HOOGSTEEN, K. H.

Molecular Pharmacology, Vol 13, 1111-1115, Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics

Calculations by Complete Neglect of Differential Overlap (CNDO/2) on Dihydrofolic Acid: Role of N(5) in Reduction by Dihydrofolate Reductase

P. GUND 1, M. POE 1, and K. H. HOOGSTEEN 1

1 Merck Sharp & Dohme Research Laboratories, Rahway, New Jersey 07065

CNDO/2 calculations on 7,8-dihydropteroylamide, a model of 7,8-dihydrofolic acid, have been made to examine the conformational and electronic properties of the molecule. The quantum mechanical calculations indicate that while the extended forms of the neutral molecule, its N(1)-cation, and N(5)-cation were favored with respect to folded forms, bent conformations are probably energetically accessible. Calculated binding energies for the protonated cations suggested that protonation at N(5) is strongly favored over N(1) by about 16.4 kcal/mole. This first site of protonation and the conformational preference agree with those observed in solution for 7,8-dihydrofolic acid. The lowest unoccupied molecular orbital (LUMO) of the N(5)-cation exhibited a much higher wave function magnitude at C(6) than did the LUMO of the N(1)-cation or the neutral molecule. Thus, according to frontier orbital theory, the N(5)-cation is especially well suited for hydride transfer to C(6). This latter result rationalizes the observed ultraviolet difference spectra of dihydrofolate reductase upon binding of dihydrofolate, indicative of protonation of dihydrofolate at N(5) upon binding. The protonation-upon-binding argument also may explain why dihydrofolate is so potently inhibited by analogues more basic than dihydrofolate in its pteridinyl moiety.

Note:
ACKNOWLEDGMENT Len Olen assisted with the calculations.

Submitted on December 29, 1976
Accepted on June 7, 1977




This article has been cited by other articles:


Home page
ScienceHome page
P Gund, J. Andose, J. Rhodes, and G. Smith
Three-dimensional molecular modeling and drug design
Science, June 27, 1980; 208(4451): 1425 - 1431.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics